Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Mills-Peninsula, Palo Alto/Santa Cruz, San Francisco, Santa Rosa, Solano/Vallejo, East Bay, Greater Sacramento Valley, San Mateo, Modesto
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A012103: OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Principal Investigator
Related Studies
Impact of COVID-19 on Cancer Care Management
Study will enhance understanding of cancer care management due to COVID-19.
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Breast Cancer Chemoprevention in Primary Care at Geisinger
Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Dana Farber 13-09-259 DCIS Registry
Molecular Characterization of Breast Cancer with Duct Forming Features
Investigator: Kristie A. Bobolis, M.D.